Țară: Statele Unite ale Americii
Limbă: engleză
Sursă: NLM (National Library of Medicine)
EPINEPHRINE (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH)
Par Pharmaceutical, Inc.
EPINEPHRINE
EPINEPHRINE 1 mg in 1 mL
INTRAMUSCULAR
PRESCRIPTION DRUG
Emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Adrenalinis indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. None. Risk Summary Prolonged experience with epinephrine use in pregnant women over several decades, based on published literature, do not identify a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. However, there are risks to the mother and fetus associated with epinephrine use during labor or delivery (see Clinical Considerations) . In animal reproduction studies, epinephrine administered by the subcutaneous route to pregnant rabbits, mice, and hamsters, during the period of organogenesis, resulted in adverse developmental effects (including gastroschisis, and embryonic lethalit
Adrenalin 1 mg/mL Single Dose Vials: Each carton contains 25 single dose vials containing 1 mg/mL Adrenalin (epinephrine injection, USP) solution in a 3 mL clear glass vial. NDC 42023-159-01 1 mL Single Dose Vial NDC 42023-159-25 25 Single Dose Vials x 1 mL each Discard unused portion. Adrenalin 30 mg/30 mL (1 mg/mL) Multiple Dose Vials: Each carton contains 1 multiple dose vial containing 30 mg/30 mL (1 mg/mL) Adrenalin (epinephrine injection, USP) solution in a 36 mL amber glass vial. NDC 42023-168-01 30 mL Multiple Dose Vial Vial and contents must be discarded 30 days after initial use. Store between 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] . Epinephrine is light sensitive. Protect from light and freezing. Inspect visually for particulate matter and discoloration prior to administration. Do not use the solution if it is colored or cloudy, or if it contains particulate matter.
New Drug Application
ADRENALIN- EPINEPHRINE INJECTION PAR PHARMACEUTICAL, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ADRENALIN SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ADRENALIN. ADRENALIN (EPINEPHRINE INJECTION) 1 MG/ML, FOR INTRAMUSCULAR, SUBCUTANEOUS, AND INTRAVENOUS USE INITIAL U.S. APPROVAL: 1939 RECENT MAJOR CHANGES Indications and Usage (1.2) 01/2019 Dosage and Administration (2.3) 01/2019 Warnings and Precautions (5.3, 5.4, 5.5, 5.6, 5.7) 01/2019 INDICATIONS AND USAGE Adrenalin is a non-selective alpha and beta adrenergic agonist indicated for: Emergency treatment of allergic reactions (Type 1), including anaphylaxis (1.1) To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock (1.2) DOSAGE AND ADMINISTRATION Anaphylaxis: _Adults and Children 30 kg (66 lbs) or more: _0.3 mg to 0.5 mg (0.3 mL to 0.5 mL) intramuscularly or subcutaneously into anterolateral aspect of the thigh every 5 to 10 minutes as necessary (2.2) _Children 30 kg (66 lbs) or less_: 0.01 mg/kg (0.01 mL/kg), up to 0.3 mg (0.3 mL), intramuscularly or subcutaneously into anterolateral aspect of the thigh every 5 to 10 minutes as necessary (2.2) Hypotension associated with septic shock: Dilute epinephrine in dextrose solution prior to infusion (2.3) Infuse epinephrine into a large vein (2.3) Intravenous infusion rate of 0.05 mcg/kg/min to 2 mcg/kg/min, titrated to achieve desired mean arterial pressure (2.3) Wean gradually (2.3) See Full Prescribing Information for instructions on dilution and administration of the injection. DOSAGE FORMS AND STRENGTHS Injection: 1 mg/mL single dose vial and 30 mg/30 mL (1 mg/mL) multiple dose vial (3) CONTRAINDICATIONS None (4) WARNINGS AND PRECAUTIONS Do not inject into buttocks, digits, hands, or feet (5.1) Avoid extravasation into tissues, which can cause local necrosis (5.3) May aggravate angina pectoris or produce ventricular arrhythmias (5.7) ADVERSE REACTIONS Common adverse react Citiți documentul complet